Sen. Klobuchar Issues Statement on Announcement of 15 More Prescription Drugs Subject to Medicare Negotiations to Lower Prices
January 18, 2025
January 18, 2025
WASHINGTON, Jan. 18 -- Sen. Amy Klobuchar, D-Minnesota, issued the following statement on Jan. 17, 2025:
* * *
U.S. Senator Amy Klobuchar (D-MN) released the following statement on today's announcement of the additional fifteen of drugs selected for Medicare negotiation. Negotiating prescription drug prices on behalf of Americans was made possible through provisions in a 2022 law based on Klobuchar's legislation to lift the nearly 20-year ban that stopped Medi . . .
* * *
U.S. Senator Amy Klobuchar (D-MN) released the following statement on today's announcement of the additional fifteen of drugs selected for Medicare negotiation. Negotiating prescription drug prices on behalf of Americans was made possible through provisions in a 2022 law based on Klobuchar's legislation to lift the nearly 20-year ban that stopped Medi . . .